Nation’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search
Rhea-AI Summary
Regeneron (NASDAQ: REGN) and Society for Science named the top 40 finalists for the Regeneron Science Talent Search 2026, representing 35 schools across 15 states and competing for more than $1.8 million in awards, including a $250,000 top prize. Finalists were selected from 300 scholars and more than 2,600 entrants based on original research. Finalists will compete March 5-11, 2026, with a public project exhibition on March 8 and winners announced March 10 in Washington, D.C. Regeneron noted its 10-year $100 million commitment and an expanded annual award distribution now totaling $3.1 million.
Positive
- $1.8M+ in awards available for 2026 finalists
- Top prize of $250,000 for scientific education
- 40 finalists selected from >2,600 entrants
- Regeneron’s 10-year $100M commitment to STS
- Annual award distribution increased to $3.1M
Negative
- None.
News Market Reaction
On the day this news was published, REGN gained 2.12%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Only one peer in momentum scanners: BNTX up about 7.83% with no linked news. Other close peers show modest single-day gains but no coordinated move tied to this education-focused announcement.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 02 | Earnings date notice | Neutral | -1.7% | Announced timing of Q4 and full-year 2025 results and call. |
| Dec 23 | Regulatory approval | Positive | +0.8% | Japan approved Dupixent for children 6–11 with severe asthma. |
| Dec 22 | Conference presentation | Neutral | +0.8% | Planned presentation at the 44th J.P. Morgan Healthcare Conference. |
| Dec 07 | Clinical data update | Positive | -2.1% | Encouraging Phase 1/2 Lynozyfic data in multiple myeloma at ASH. |
| Dec 01 | Collaboration deal | Positive | -3.9% | Global TSRA-196 gene editing collaboration with Tessera for AATD. |
Recent history shows several positive or neutral updates followed by mixed to negative price reactions, particularly around clinical data and collaboration news.
Over the last few months, Regeneron has reported a mix of clinical, strategic, and event-related updates. A collaboration on TSRA-196 for AATD with Tessera, including $150 million upfront/equity and $125 million in milestones, saw a -3.86% reaction. Strong Phase 1/2 Lynozyfic multiple myeloma data coincided with a -2.1% move. By contrast, a positive Dupixent pediatric asthma approval in Japan and a J.P. Morgan conference presentation each aligned with modest +0.75% reactions. The current STEM competition news fits Regeneron’s long-running science education and CSR narrative rather than a direct financial catalyst.
Market Pulse Summary
This announcement highlights Regeneron’s expanded commitment to STEM education via the Science Talent Search, featuring 40 finalists across 15 states competing for over $1.8 million in awards and a top prize of $250,000. Regeneron’s 10‑year, 100 million commitment and increased annual awards to $3.1 million reinforce its long-term STEM-Fueled strategy. In context with recent clinical, collaboration, and earnings updates, this news underscores the company’s broader emphasis on scientific leadership and talent development rather than near-term financial impact.
AI-generated analysis. Not financial advice.
The Regeneron Science Talent Search Honors America’s Brightest Young Scientists Advancing Discovery and Innovation
TARRYTOWN N.Y. and WASHINGTON, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Society for Science (the Society) and Regeneron today announced the top 40 finalists in the Regeneron Science Talent Search 2026, America’s oldest and most prestigious science and math competition for high school seniors.
Key Takeaways:
- The Regeneron Science Talent Search 2026 finalists represent 35 schools across 15 states. They are competing for more than
$1.8 million , with a top prize of$250,000 t o further their scientific education. - 40 finalists were chosen from 300 top scholars, and more than 2,600 total entrants were selected based on the originality and creativity of their scientific research, as well as their achievement and leadership both inside and outside the classroom.
- Finalists will participate in a week-long competition from March 5-11, 2026, engaging in a rigorous judging process and competing for awards that recognize their excellence and can be used toward their education.
- They will also have an opportunity to interact with leading scientists and share research with the public on March 8, 2026.
- The top 10 Regeneron Science Talent Search 2026 winners will be announced during an awards ceremony on March 10, streamed live from Washington D.C.
- For a list of this year’s finalists, see here: https://www.societyforscience.org/regeneron-sts/2026-finalists/.
In its 85th year, the competition continues to spotlight exceptional young scientists whose technical excellence and leadership drive meaningful impact. Its alumni include 13 Nobel laureates, 23 MacArthur Fellows, eight Breakthrough Prize winners, and founders of influential science-driven companies such as Regeneron.
“My own scientific journey can be traced back to my experience with the Science Talent Search, which profoundly shaped who I am today. Participating in and becoming a winner of STS gave me the confidence to dedicate my life to science and the pursuit of inventing medicines that improve people’s lives,” said George D. Yancopoulos, M.D., Ph.D., co-Founder, co-Chairman, President, and Chief Scientific Officer at Regeneron, and a 1976 STS Winner. “Today, Regeneron helps millions of people around the world facing serious diseases, which is a testament to what is possible when young scientific talent is nurtured. I see that same potential to transform our world in these finalists, and I eagerly await their future contributions to science and humanity.”
Finalist research projects cover 16 categories, from Computer Science to Environmental Science. Other finalists chose to focus on Behavioral Sciences. The top 4 categories among finalist projects this year are:
- Computer Science
- Computational Biology and Bioinformatics
- Mathematics
- Medicine and Health
“We are immensely proud to celebrate this extraordinary class of Regeneron Science Talent Search finalists and their remarkable achievements,” said Maya Ajmera, President and CEO of Society for Science and Executive Publisher of Science News. “As they build on a powerful 85-year legacy of scientific innovation, they are propelled by the strength and support of a dynamic scientific community.”
What’s Next: Important Dates for 2026
- Regeneron STS Finalists Week: March 5-11, 2026
- Public Exhibition of Projects: March 8, 2026
- Winners Announced at Awards Ceremony: March 10, 2026
Resources:
What is the Regeneron Science Talent Search?
The Regeneron Science Talent Search, a program of Society for Science since 1942, is the United States’ oldest and most prestigious science and math competition for high school seniors. Each year, more than 2,000 student entrants submit original research in critically important scientific fields of study and are judged by leading experts in their fields. Unique among high school competitions in the U.S. and around the world, the Regeneron Science Talent Search focuses on identifying, inspiring and engaging the nation’s most promising young scientists who are generating innovative solutions to solve significant global challenges through rigorous research and discoveries. It provides students with a national stage to present new ideas and challenge conventional ways of thinking.
For over eight decades, the Science Talent Search has rewarded talented high school seniors who dedicate countless hours to original research projects and present their results in rigorous reports that resemble graduate school theses. Collectively, STS alumni have received millions of dollars in scholarships and gone on to be awarded Nobel Prizes, Fields Medals, MacArthur Fellowships and numerous other accolades.
What is Regeneron’s role?
In 2017, Regeneron became only the third sponsor of the Science Talent Search, with a 10 year 100 million commitment to help reward and celebrate the best and brightest young minds and encourage them to pursue careers in STEM as a way to positively impact the world. Throughout our partnership, Regeneron nearly doubled the overall award distribution to
Learn more at https://www.societyforscience.org/regeneron-sts/.
What is Society for Science?
Society for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge, and its STEM Outreach programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate and inspire. Learn more at www.societyforscience.org and follow us on Facebook, Twitter, Instagram, and LinkedIn.
What is Regeneron?
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops, and commercializes potentially life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic conditions, infectious diseases, and rare diseases.
Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity and excellence, and to build sustainable communities. Our most significant philanthropic investments are in science education, a commitment we call STEM-Fueled™ – our collection of programs and partnerships, including the Regeneron Science Talent Search (STS) and the Regeneron International Science and Engineering Fair (ISEF), that fuel future scientific innovators to pursue bold ideas and advance world-changing solutions. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro bono, and matching gift programs. We are proud to be recognized on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the United States.
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.
Media Contacts
Gayle Kansagor, Society for Science
703-489-1131, gkansagor@societyforscience.org
Tina Parisi Tuttle, Regeneron
914-847-3511, tinaparisituttle@regeneron.com
FAQ
What awards is Regeneron offering for the Regeneron Science Talent Search 2026 (REGN)?
When will Regeneron Science Talent Search 2026 winners for REGN be announced?
How many students entered and how many finalists were named in Regeneron STS 2026 (REGN)?
What is Regeneron’s financial commitment to the Science Talent Search program (REGN)?
When can the public view Regeneron STS 2026 finalist projects (REGN)?
How does the Regeneron Science Talent Search 2026 (REGN) select finalists?
